肾移植中继发于具有肾意义的单克隆丙种球蛋白病的复发性膜增生性肾小球肾炎经硼替佐米成功治疗。 - Suppr

Suppr

超能文献

Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.

作者信息

Chow Ke Li, Kanellis John, Dayan Sukhpal, Ryan Jessica

机构信息

Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia.

Department of Pathology, Monash Medical Centre, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2019 Jun;49(6):801-802. doi: 10.1111/imj.14313.

DOI:10.1111/imj.14313

PMID:31185533

Abstract

摘要

相似文献

Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.

Intern Med J. 2019 Jun;49(6):801-802. doi: 10.1111/imj.14313.

[Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].

G Ital Nefrol. 2019 Jul 24;36(4):2019-vol4.

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.

BMC Nephrol. 2018 May 3;19(1):108. doi: 10.1186/s12882-018-0905-6.

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Clin J Am Soc Nephrol. 2010 May;5(5):770-82. doi: 10.2215/CJN.06760909. Epub 2010 Feb 25.

Monoclonal gammopathy of renal significance with heavy-chain deposition disease in renal allograft: challenges in the diagnosis and management.

Transpl Int. 2019 Jul;32(7):769-770. doi: 10.1111/tri.13461. Epub 2019 May 31.

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.

BMC Nephrol. 2018 Jun 8;19(1):129. doi: 10.1186/s12882-018-0927-0.

Cyclophosphamide for the Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.

Saudi J Kidney Dis Transpl. 2021 Jul-Aug;32(4):1166-1170. doi: 10.4103/1319-2442.338293.

Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.

Nephrology (Carlton). 2017 Feb;22 Suppl 1:15-17. doi: 10.1111/nep.12934.

Dense deposit disease in association with monoclonal gammopathy of unknown significance.

Nephrol Dial Transplant. 1996 Nov;11(11):2309-12. doi: 10.1093/oxfordjournals.ndt.a027156.

Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.

BMC Nephrol. 2016 Jan 11;17:7. doi: 10.1186/s12882-015-0219-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.

作者信息

Chow Ke Li, Kanellis John, Dayan Sukhpal, Ryan Jessica

机构信息

Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia.

Department of Pathology, Monash Medical Centre, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2019 Jun;49(6):801-802. doi: 10.1111/imj.14313.

DOI:10.1111/imj.14313

PMID:31185533

Abstract

摘要

相似文献

Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.

Intern Med J. 2019 Jun;49(6):801-802. doi: 10.1111/imj.14313.

[Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].

G Ital Nefrol. 2019 Jul 24;36(4):2019-vol4.

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.

BMC Nephrol. 2018 May 3;19(1):108. doi: 10.1186/s12882-018-0905-6.

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Clin J Am Soc Nephrol. 2010 May;5(5):770-82. doi: 10.2215/CJN.06760909. Epub 2010 Feb 25.

Monoclonal gammopathy of renal significance with heavy-chain deposition disease in renal allograft: challenges in the diagnosis and management.

Transpl Int. 2019 Jul;32(7):769-770. doi: 10.1111/tri.13461. Epub 2019 May 31.

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.

BMC Nephrol. 2018 Jun 8;19(1):129. doi: 10.1186/s12882-018-0927-0.

Cyclophosphamide for the Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition.

Saudi J Kidney Dis Transpl. 2021 Jul-Aug;32(4):1166-1170. doi: 10.4103/1319-2442.338293.

Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.

Nephrology (Carlton). 2017 Feb;22 Suppl 1:15-17. doi: 10.1111/nep.12934.

Dense deposit disease in association with monoclonal gammopathy of unknown significance.

Nephrol Dial Transplant. 1996 Nov;11(11):2309-12. doi: 10.1093/oxfordjournals.ndt.a027156.

Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.

BMC Nephrol. 2016 Jan 11;17:7. doi: 10.1186/s12882-015-0219-x.